PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 27 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $78,518 | -28.8% | 47,300 | -14.2% | 0.00% | – |
Q2 2023 | $110,250 | -73.0% | 55,125 | -71.6% | 0.00% | -100.0% |
Q1 2023 | $407,597 | +2838.1% | 194,094 | +1816.8% | 0.00% | – |
Q4 2022 | $13,873 | +26.1% | 10,126 | -2.2% | 0.00% | – |
Q3 2022 | $11,000 | -60.7% | 10,351 | -59.4% | 0.00% | – |
Q2 2022 | $28,000 | – | 25,510 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,414,487 | $9,416,000 | 0.51% |
Measured Wealth Private Client Group, LLC | 38,116 | $148,000 | 0.07% |
Psagot Value Holdings Ltd. | 470,255 | $1,820,000 | 0.05% |
Phoenix Holdings Ltd. | 204,355 | $751,000 | 0.03% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 300,000 | $1,161,000,000 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 212,591 | $823,000 | 0.02% |
KENNEDY CAPITAL MANAGEMENT LLC | 149,151 | $577,000 | 0.02% |
ETF MANAGERS GROUP, LLC | 101,768 | $397,000 | 0.01% |
HAP Trading, LLC | 100,400 | $108,000 | 0.01% |
Squarepoint Ops LLC | 44,679 | $173,000 | 0.00% |